PURPOSE: The aim of this report was to present an integrated 3-dimensional (3D) virtual approach toward cone-beam computed tomography-based treatment planning of orthognathic surgery in the clinical routine. MATERIALS AND METHODS: We have described the different stages of the workflow process for routine 3D virtual treatment planning of orthognathic surgery: 1) image acquisition for 3D virtual orthognathic surgery; 2) processing of acquired image data toward a 3D virtual augmented model of the patient's head; 3) 3D virtual diagnosis of the patient; 4) 3D virtual treatment planning of orthognathic surgery; 5) 3D virtual treatment planning communication; 6) 3D splint manufacturing; 7) 3D virtual treatment planning transfer to the operating room; and 8) 3D virtual treatment outcome evaluation. CONCLUSIONS: The potential benefits and actual limits of an integrated 3D virtual approach for the treatment of the patient with a maxillofacial deformity are discussed comprehensively from our experience using 3D virtual treatment planning clinically.
PURPOSE: The aim of this report was to present an integrated 3-dimensional (3D) virtual approach toward cone-beam computed tomography-based treatment planning of orthognathic surgery in the clinical routine. MATERIALS AND METHODS: We have described the different stages of the workflow process for routine 3D virtual treatment planning of orthognathic surgery: 1) image acquisition for 3D virtual orthognathic surgery; 2) processing of acquired image data toward a 3D virtual augmented model of the patient's head; 3) 3D virtual diagnosis of the patient; 4) 3D virtual treatment planning of orthognathic surgery; 5) 3D virtual treatment planning communication; 6) 3D splint manufacturing; 7) 3D virtual treatment planning transfer to the operating room; and 8) 3D virtual treatment outcome evaluation. CONCLUSIONS: The potential benefits and actual limits of an integrated 3D virtual approach for the treatment of the patient with a maxillofacial deformity are discussed comprehensively from our experience using 3D virtual treatment planning clinically.
Authors: Rania M Nada; Bram van Loon; Thomas J J Maal; Stefaan J Bergé; Yehya A Mostafa; Anne Marie Kuijpers-Jagtman; Jan G J H Schols Journal: Clin Oral Investig Date: 2013-02-02 Impact factor: 3.573
Authors: M A E M Wagenmakers; S H P P Roerink; T J J Maal; R H Pelleboer; J W A Smit; A R M M Hermus; S J Bergé; R T Netea-Maier; T Xi Journal: Pituitary Date: 2015-02 Impact factor: 4.107
Authors: Stacey L Clark; John F Teichgraeber; Ruth G Fleshman; Joi D Shaw; Carmen Chavarria; Chung-How Kau; Jaime Gateno; James J Xia Journal: J Craniofac Surg Date: 2011-01 Impact factor: 1.046
Authors: J J Xia; J Gateno; J F Teichgraeber; P Yuan; K-C Chen; J Li; X Zhang; Z Tang; D M Alfi Journal: Int J Oral Maxillofac Surg Date: 2015-12 Impact factor: 2.789
Authors: J J Xia; J Gateno; J F Teichgraeber; P Yuan; J Li; K-C Chen; A Jajoo; M Nicol; D M Alfi Journal: Int J Oral Maxillofac Surg Date: 2015-12 Impact factor: 2.789